Alpha Quant Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$1.17M |
| 2 |
NRG Energy
NRG
|
+$882K |
| 3 |
Southwest Airlines
LUV
|
+$321K |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$268K |
| 5 |
Stryker
SYK
|
+$246K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$1.6M |
| 2 |
Intuit
INTU
|
+$1.14M |
| 3 |
Delta Air Lines
DAL
|
+$992K |
| 4 |
Biogen
BIIB
|
+$331K |
| 5 |
International Flavors & Fragrances
IFF
|
+$285K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.78% |
| 2 | Technology | 17.86% |
| 3 | Consumer Staples | 15.81% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 8.71% |
Similar funds
Alpha Quant Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, Alpha Quant Advisors held 423 positions worth $99.8M, up 3.5% from $96.4M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Alpha Quant Advisors withdrew a net $5.41M in Q1 2019, closing 73 positions and reducing 101 holdings. Its most notable exit was International Flavors & Fragrances, an estimated $285K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Alpha Quant Advisors opened a new position in Alexion Pharmaceuticals worth $291K.
- Alpha Quant Advisors's largest Q1 2019 buy was Alexion Pharmaceuticals: 2,155 shares worth $291K.
- Alpha Quant Advisors added most to Clorox in Q1 2019, an estimated $1.17M increase.
- Alpha Quant Advisors's biggest Q1 2019 reduction was Cigna, cutting an estimated $1.6M.
- Alpha Quant Advisors fully exited International Flavors & Fragrances in Q1 2019, selling an estimated $285K.
- Alpha Quant Advisors's ten largest holdings make up 18% of its $99.8M portfolio in Q1 2019.
- Alpha Quant Advisors opened 64 new positions and closed 73 in Q1 2019.
- Alpha Quant Advisors's portfolio value rose 3.5% quarter-over-quarter to $99.8M.
Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.